key: cord-0722251-170naj2r
authors: Resende, P. C.; Naveca, F. G.; Lins, R. D.; Dezordi, F. Z.; Ferraz, M. V. F.; Moreira, E. G.; Coelho, D. F.; Motta, F. C.; Paixao, A. C. D.; Appolinario, L.; Lopes, R. S.; Mendonca, A. C. d. F.; da Rocha, A. S. B.; Nascimento, V.; Souza, V.; Silva, G.; Nascimento, F.; Neto, L. G. L.; Riediger, I.; Debur, M. d. C.; Leite, A. B.; Mattos, T.; da Costa, C. F.; Pereira, F. M.; Khouri, R.; Bernardes, A. F. L.; Delatorre, E.; Graf, T.; Siqueira, M. M.; Bello, G.; Wallau, G. L.; Network, Fiocruz COVID-19 Genomic Surveillance
title: The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the Spike protein
date: 2021-03-20
journal: nan
DOI: 10.1101/2021.03.19.21253946
sha: 918b52fd8967d69436f3d3c0dfb61b0940541d2b
doc_id: 722251
cord_uid: 170naj2r

Mutations at both the receptor-binding domain (RBD) and the amino (N)-terminal domain (NTD) of the SARS-CoV-2 Spike (S) glycoprotein can alter its antigenicity and promote immune escape. We identified that SARS-CoV-2 lineages circulating in Brazil with mutations of concern in the RBD independently acquired convergent deletions and insertions in the NTD of the S protein, which altered the NTD antigenic-supersite and other predicted epitopes at this region. These findings support that the ongoing widespread transmission of SARS-CoV-2 in Brazil is generating new viral lineages that might be more resistant to neutralization than parental variants of concern.

glycoprotein of SARS-CoV-2 has been identified during long-term infection of immunocompromised patients [1] [2] [3] [4] as well as during extended human-to-human transmission 3 . Most of those deletions (90%) maintain the reading frame and cover four recurrent deletion regions (RDRs) within the NTD at positions 60-75 (RDR1), 139-146 (RDR2), 210-212 (RDR3), and 242-248 (RDR4) of the S protein 3 . The RDRs that occupy defined antibody epitopes within the NTD and RDR variants might alter antigenicity 3 . Interestingly, the RDRs overlap with four Indel Regions (IR) at the NTD (IR-2 to IR-5) that are prone to gain or lose short nucleotide sequences during sarbecoviruses evolution both in animals and humans 5, 6 .

Since late 2020, several more transmissible variants of concern (VOCs) and also variants of interest (VOI) with convergent mutations at the receptor-binding domain (RBD) of the S protein (particularly E484K and N501Y) arose independently in humans 7, 8 . Some VOCs also displayed NTD deletions like lineages B. Several SARS-CoV-2 variants with mutations in the RBD have been described in Brazil, including the VOC P.1 15 and the VOIs P.2 16 and N.9 17 . The VOC P.1 also displayed NTD mutations (L18F) that abrogate binding of some anti-NTD mAbs 14 , but none of those variants displayed indels in the NTD. Importantly, although VOC P.1 showed reduced binding to RBD-directed antibodies, it is more susceptible to anti-NTD mAbs than other VOCs [9] [10] [11] [12] [13] [14] . In this study, we monitored and characterized the emergence of RDR variants within VOC and VOI circulating in Brazil that were genotyped by the Fiocruz COVID-19 Genomic Surveillance Network between November 2020 and February 2021.

Our genomic survey identified 11 SARS-CoV-2 sequences from five different Brazilian states (Amazonas, Bahia, Maranhao, Parana, and Rondonia) that harbor a . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint *Patient from Amazonas state or traveller returning from Amazonas state. ** Patient from Rondonia.

The Maximum Likelihood (ML) phylogenetic analyses showed that P.1 variants 141-144 were intermixed among non-deleted sequences (Fig. 1A) . The four P.1 144 sequences detected in Bahia state; however, branched in a subclade (aLRT = 77%) together with the 189-190 variant and the other two lineages P.1 sequences that share the synonymous mutation A18945G (Fig. 1A) . The four P.1-like ins214ANRN and the two B.1.1.33(E484K) 141-144/211/256-258 variants also clustered in highly supported (aLRT = 100%) monophyletic clades ( Fig. 1A is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table 1 ). Most ins214 motifs were unique, except ins214TDR, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 20, 2021. ;  rectangles highlight the indels identified in this study. The identity level estimated for each position of the alignment is displayed at the top.

Epitope mapping showed that neutralizing antibodies are primarily directed against the RBD and NTD of the S protein 9,20-23 . Some of the RBD mutations (K417T and E484K) detected in the VOCs and VOIs circulating in Brazil have been associated with increased resistance to neutralization by mAbs, or polyclonal sera from convalescent and vaccinated subjects [24] [25] [26] [27] (residues 141 to 156) and N5 (residues 246 to 260) loops that composes the NTD antigenic-supersite 28, 29 and confers resistance to neutralization by anti-NTD mAbs 3, 9, 10, 30 . Moreover, in vitro co-incubation of SARS-CoV-2 with highly neutralizing plasma form COVID-19 convalescent patient, has revealed an incremental resistance to neutralization followed by the stepwise acquisition of indels at N3/N5 loops 31 Thus, NTD indels might represent a mechanism of ongoing adaptive evolution of VOC and VOI circulating in Brazil to escape from dominant neutralizing antibodies directed against the NTD antigenic-supersite.

To test this hypothesis, we performed a modeling analysis of the binding interface between wildtype/indels NTD variants and the NTD-directed neutralizing antibody (NAb) 2-51 derived from a convalescent donor 20 . The NAb 2-51 makes several contacts with the wildtype NTD antigenic-supersite (EPI_ISL_402124), primarily through the heavy-chain (Fig. 3) . The loops N3 and N5 play a pivotal role in the binding process with a predominance of hydrophobic contacts and dispersion interactions in N5 and saline interactions in N3. Our result shows that deletions at RDR 2 ( 144, 141-143) and RDR4 ( 242-244) impact the loops' size and conformation, disrupting the native contacts and reducing the interacting hydrophobic surface accessible area, mainly due to the loss of the hydrophobic pocket ( Figure S1 ). Indels around the N3/N5 loops resulted in a significant loss of interactions (both electrostatic and hydrophobic) ( Table 2 ) that will dramatically impact the binding free energy, and therefore the binding affinity, between those NTD deletion variants and the NAb 2-51.

Although NTD indels 189-190 and ins214ANRN did not affect the NTD antigenic-supersite, they occur at putative epitope regions covering residues . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table 2 ) and leads to conformational changes in exterior loops (Figure S1 G-H) which might affect Ab binding outside the antigenic-supersite. These findings suggest that NTD deletions 144, 141-143, and 242-244 here detected probably abrogate the binding of NAb directed against the NTD antigenic-supersite and confirm that deletions at RDRs 2/4 are an essential mechanism for SARS-CoV-2 immune evasion 3,14 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.19.21253946 doi: medRxiv preprint atoms in cyan, nitrogen atoms in blue and oxygen atoms in red. The dotted lines indicate the interacting residues-pair. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

B.1.1.28 144 -2 -3 -1 -1 K147-E71 K150-E53 K150-D54 Y145-Y98 P.2 144 -2 -3 -1 -104 K147-E71 K150-E53 K150-D54 Y145-Y98 P.1 144 -2 -3 -1 -111 K147-E71 K150-E53 K150-D54 Y145-

Our genomic survey of SARS-CoV-2 positive samples sequenced by the Fiocruz

February 2021 identified 11 sequences with mutations of concern in the RBD and indels in the NTD (Appendix 1) . The SARS-CoV-2 genomes were recovered using Illumina sequencing protocols as previously described 33, 34 . The FASTQ reads obtained were Table 1 ). This study was approved by the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 20, 2021. ;  in EpiCoV database in the GISAID (https://www.gisaid.org/) at March 1st, 2021 and subjected to maximum-likelihood (ML) phylogenetic analysis using IQ-TREE v2.1.2 38 .

The S amino acid sequences from selected SARS-CoV-2 and SC2r-CoV lineages available in the EpiCoV database were also aligned using Clustal W 39 adjusted by visual inspection.

The resolved crystallographic structure of SARS-CoV-2 NTD protein bound to the neutralizing antibody 2-51 was retrieved from the Protein Databank (PDB) under the accession code 7L2C 28 . Missing residues of the chain A, corresponding to the NTD coordinates, were modeled using the user template mode of the Swiss-Model webserver (https://swissmodel.expasy.org/) 40 and was used as starting structure for the NTD wildtype. This structure was then used as a template to model the NTD variants using the Swiss-Model. The modeled structures of the NTDs variants were superimposed onto the coordinates of the PDB ID 7L2C to visualize the differences between the NTD-antibody binding interfaces. Image rendering was carried out using Visual Molecular Dynamics (VMD) software 41 . The NTD-antibodies complexes were geometry optimized using a maximum of 5,000 steps or until it reached a convergence value of 0.001 REU (Rosetta energy units) using the limited-memory BroydenFletcher-Goldfarb-Shanno algorithm, complying with the Armijo-Goldstein condition, as implemented in the Rosetta suite of software 3.12 42 

Epitopes in the NTD region were predicted by the ElliPro Antibody Epitope Prediction server 46 . NTD are shown as predicted linear epitopes when using PDB accession codes . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.19.21253946 doi: medRxiv preprint 6VXX 47 and 6VSB 48 , (structural coordinates corresponding to the entire S protein), along with a minimum score of 0.9, i.e., a highly strict criterion.

The authors wish to thank all the health care workers and scientists who have worked hard to deal with this pandemic threat, the GISAID team, and all the EpiCoV database's submitters, GISAID acknowledgment table containing sequences used in this study are attached to this post (Appendix Table 3 ). We also appreciate the support of the Fiocruz 

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

SARS-CoV-2 evolution during treatment of chronic infection

Spike protein mutations in novel SARS-CoV-2 'variants of concern' commonly occur in or near indels

Spike protein sequences of Cambodian, Thai and Japanese bat sarbecoviruses provide insights into the natural evolution of the Receptor Binding Domain and S1/S2 cleavage site

Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein

Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations -SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology

Spike mutations in SARS-CoV-2 variants confer resistance to antibody neutralization

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity

Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings -SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil

Early genomic detection of SARS-CoV-2 P.1 variant in Northeast Brazil

Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant

Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma

The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape

Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil

SARS-CoV-2 genomes recovered by long amplicon tiling multiplex approach using nanopore sequencing and applicable to other sequencing platforms

Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil

A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data

karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data

IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies

Clustal W and Clustal X version 2.0

SWISS-MODEL: homology modelling of protein structures and complexes

VMD: Visual molecular dynamics

ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules

PIC: Protein Interactions Calculator

Inference of Macromolecular Assemblies from Crystalline State

RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite

ElliPro: a new structure-based tool for the prediction of antibody epitopes

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein